| |
Founders
| |
Beth Rosenshein
Beth is an
electrical/bio-medical engineer. She has three United States patents,
one for a unique design of a vaginal speculum, and one for a clever
urinary collection device specifically designed for women and one for an
intravaginal data collection device. Beth discovered and documented an
important drug interaction between esomeprazole (Nexium™) and
testosterone. Her findings were published in a case study in The
American Journal of the Medical Sciences in May 2004. She petitioned the
FDA in August 2003 to change the labeling on hormone products. The
petition was granted in September 2004 changing the labeling on all
estrogen products. Beth is also a wife and mother and lives in Boulder,
CO.
|
| |
Leon Rosenshein
Leon is a mechanical/aerospace engineer with an MBA currently working
in the software industry. He has served on the board of several
non-profit organizations.
|
| |
Together, Leon and Beth founded Diamond Research Foundation.
|
Medical Director
| |
Susan Marcolina, MD, FACP |
|
